B. Abboa-Offei

发表

Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308).

S. Spergel, N. Murugesan, Z. Gu, 1998, Journal of medicinal chemistry.

Beta 3 agonists. Part 1: evolution from inception to BMS-194449.

R. Gregg, A. Mathur, T. Waldron, 2001, Bioorganic & medicinal chemistry letters.

BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptor.

A. Mathur, T. Waldron, K. Dickinson, 2001, Bioorganic & medicinal chemistry letters.

Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase.

N. Trippodo, H. Cheung, R. Misra, 1997, Journal of medicinal chemistry.

Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.

J. Hunt, B. Abboa-Offei, A. Seymour, 1991, The Journal of pharmacology and experimental therapeutics.

SODIUM LOADS ENHANCE THE NATRIURETIC RESPONSES TO ATRIAL NATRIURETIC PEPTIDE AND NEUTRAL ENDOPEPTIDASE INHIBITORS IN CONSCIOUS CYNOMOLGUS MONKEYS

B. Abboa-Offei, A. Seymour, P. Smith, 1994, Clinical and experimental pharmacology & physiology.

POTENTIATION OF NATRIURETIC PEPTIDES BY NEUTRAL ENDOPEPTIDASE INHIBITORS

B. Abboa-Offei, P. Mathers, A. Seymour, 1995, Clinical and experimental pharmacology & physiology.

Pulmonary function changes in normal rats induced by antibody against rat IgE.

B. Abboa-Offei, F. Casey, 1979, Clinical and experimental immunology.

Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors.

B. Abboa-Offei, P. Mathers, A. Seymour, 1996, Journal of cardiovascular pharmacology.

Renal and depressor activities of inhibitors of neutral endopeptidase and angiotensin converting enzyme in monkeys infused with angiotensin II.

B. Abboa-Offei, P. Mathers, A. Seymour, 1996, Journal of cardiovascular pharmacology.

Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.

B. Abboa-Offei, A. Seymour, S. Fennell, 1992, The Journal of pharmacology and experimental therapeutics.

Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature

S. Moreland, B. Abboa-Offei, A. Seymour, 1994, British journal of pharmacology.

Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

R. Parker, L. Hamann, M. Kirby, 2005, Journal of medicinal chemistry.

In vivo pharmacology of dual neutral endopeptidase/angiotensin-converting enzyme inhibitors.

B. Abboa-Offei, A. Seymour, P. Smith, 1996, Journal of cardiovascular pharmacology.

Anti‐allergic properties of pirquinozol (SQ 13,847) an orally effective agent. Evaluation in an anti‐IgE‐induced pulmonary function model in rats

B. Abboa-Offei, F. Casey, 1983, The Journal of pharmacy and pharmacology.

Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo.

B. Abboa-Offei, F. Casey, J. Marretta, 1980, The Journal of pharmacology and experimental therapeutics.

Antihypertensive Activity During Inhibition of Neutral Endopeptidase and Angiotensin Converting Enzyme

J. Swerdel, B. Abboa-Offei, A. Seymour, 1991, Journal of cardiovascular pharmacology.

Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitors.

R. Parker, L. Hamann, D. Augeri, 2004, Journal of medicinal chemistry.

BMS-201620: a selective beta 3 agonist.

T. Waldron, K. Dickinson, R. George, 2004, Bioorganic & medicinal chemistry letters.